GFF•November 18, 2026 at 10:19 PM UTCCapital Goods

Strong Q4 Execution, Soft Markets, and a Stretched Valuation Keep Griffon a Hold

Read source article

What happened

Griffon has executed a portfolio restructuring that refocuses the company on building products, with the AMES consumer tools business reclassified as discontinued operations and a joint venture deal expected to close by June 2026. However, Q1 FY2026 results revealed margin compression in the core Home and Building Products segment, as a 4% volume decline and rising input costs offset a 7% price/mix gain, pushing adjusted EBITDA margin down to 30.1% from 32.1% a year earlier. The stock experienced a strong rally from $73 in March 2026 to $107 by November, but an updated analysis now values the shares at $94, implying a 14% downside. Management has guided to flat FY2027 revenue and EBITDA, and with residential volumes declining and steel costs rising, the ability to sustain premium pricing is questioned. Given the valuation premium relative to historical free cash flow multiples and the lack of near-term growth catalysts, a Hold rating remains appropriate.

Implication

The stock's rally has pushed it to a valuation that discounts an optimistic scenario, leaving little margin of safety. The core HBP segment faces structural headwinds from declining residential repair-and-remodel demand and rising steel costs, which could compress margins below the 30% target if pricing power fades. The upcoming discontinued operations reporting and ONCAP JV closure are near-term catalysts, but they may introduce earnings volatility and one-time charges. With flat guidance for FY2027, the market may be overestimating the company's ability to grow earnings, and a re-rating to the five-year average free cash flow multiple would imply significant downside. Consequently, existing holders should consider trimming positions above $88 (as suggested by the DeepValue framework), while potential buyers should wait for a pullback toward the $62 attractive entry level or clear evidence of margin stabilization.

Thesis delta

The original thesis emphasized patience pending Q2 margin evidence and ONCAP JV closure, with an attractive entry at $62. However, after a strong rally to $107, the stock now trades above our fair value estimate of $94, eroding the margin of safety. The thesis shifts from 'wait for a better entry' to 'hold existing positions only, with a bias to trim on strength, as valuation now reflects optimistic assumptions while fundamental headwinds persist.'

Confidence

Medium